ICH M4E - Common Technical Document - Efficacy

What it says

The Efficacy module of a marketing application must be organized in a defined structure presenting clinical study reports, biopharmaceutic studies and other efficacy-related clinical data, following a harmonized format that allows the same core clinical efficacy data package to support applications across multiple ICH regions, completing the three-module structure alongside ICH M4Q and ICH M4S.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

• Together with ICH M4Q and ICH M4S, this module completes the harmonized Common Technical Document structure, and consistency across all three modules matters because reviewers routinely cross-reference claims made in one module against supporting data presented in another.
• Biopharmaceutic study data presented in this module, such as bioavailability and food-effect studies, often connects directly back to formulation and manufacturing decisions documented in the Quality module.
• Clinical dosing information established in this module's efficacy data must remain consistent with the dosage and administration information presented in the product's approved labeling.

What inspectors look for

• Whether dosing and administration information in current labeling remains consistent with the efficacy data and clinical study results presented in this module.
• Whether biopharmaceutic study data referenced here, such as food-effect or bioavailability findings, is consistent with the formulation currently being manufactured.
• Whether any formulation change since approval was assessed for whether it could affect the biopharmaceutic basis supporting the original efficacy data.

Related regulations